The biotransformation of the clerodane diterpene, 3,12-dioxo-15,16-epoxy-4-hydroxy-cleroda-13(16),14-diene (1), obtained from Croton micans var. argyroglossum (Baill.) Müll., was investigated for the first time. Whole cells of Cunninghamella echinulata and Rhizopus stolonifer were used as enzymatic systems, and with both fungi the only biotransformation product obtained was the new ent-neo-clerodane diterpene (3R,4S,5S,8S,9R,10S)-3,4-dihydroxy-15,16-epoxy-12-oxo-cleroda-13(16),14-diene (2a). The absolute stereochemistry of 2a was inferred by comparison of its optical rotation with those of the chemical reduction product of 1 and its quasienantiomer 2c.
Microbial biotransformation of natural products represents an alternative tool for the production of new bioactive compounds of interest to the pharmaceutical and chemical industries. Because most biotransformation reactions are chemo-, regio-, and stereoselective, this methodology has gained interest as a tool in organic synthesis, since desired compounds can be produced under environmentally friendly conditions [1] . In our continuing research program on the production of novel and/or bioactive compounds by microbial transformation of natural products [2] [3] [4] , we investigated the biotransformation of the clerodane diterpene 1, obtained in high yield from Croton micans var. argyroglossum. Previous studies on biotransformation of diterpenes by whole cells of fungi have led to a variety of products, mainly formed by oxidative processes [5] [6] [7] [8] . Herein, we report an efficient stereo and regioselective bioreduction of the C-3 carbonyl group of 1, yielding exclusively the -hydroxy product 2a.
Compound 1 (Figure 1 ) was isolated in ca. 4.0 % yield from the nhexane extract of the roots of C. micans var. argyroglossum. Its spectroscopic data ( 1 H NMR, 13 C NMR and MS) were identical with those of 3,12-dioxo-15,16-epoxy-4-hydroxycleroda-13(16),14diene (1) previously isolated from C. argyrophylloides [9] and C. hovarum [10] . The relative stereochemistry of 1 has previously been established by X-ray analysis [9] . The microbial biotransformation of 1 was first investigated using whole cells of Cunninghamella echinulata var. elegans and Rhizopus stolonifer, two fungi known for their potential for biotransformation of diterpenes [5, 6] . The growing cells of C. echinulata and R. stolonifer biotransformed compound 1 in 2 and 7 days, respectively. TLC analysis of the crude extracts revealed the formation of only one product in each experiment, and suggested these to be the same compound. This biotransformation product was isolated in high yields (96 % from C. echinulata var. elegans and 62 % from R. stolonifer), and was identified as 2a by spectroscopic analysis. It is noteworthy that no additional biotransformation products were formed, even after incubation of 1 with both microorganisms for 15 days. The 13 C NMR spectrum of the biotransformation product was very similar to that of the starting material 1. The lack of the peak at  215.32 (carbonyl group at C-3) and the presence of one at  72.36 in the spectrum confirmed that compound 1 was regioselectively bioreduced at C-3 to afford either 2a or 2b (Figure 1 ).
Figure 1:
Chemical structures of the ent-neo trans-clerodane diterpene 3,12-dioxo-15,16-epoxy-4-hydroxycleroda-13(16),14-diene (1) and its reduction products 2a and 2b.
The relative stereochemistry of C-3 in 2a was established by NOEDIFF experiment. Irradiation of the proton at C-3 ( 3.78) enhanced the signal at  1.20 (Me-19), confirming the β orientation of the C-3 proton. Compound 2b (Figure 1 ), which is a C-3 epimer of 2a, is reported in the literature as both a natural plant product [10, 11] and a synthetic compound produced by the chemical reduction of 1 [9] . Thus, for comparison, compound 1 was chemically reduced with NaBH 4 and 2b was isolated as the major product (64 % yield) ( Figure 1 ). NMR analysis of 2b corroborated this compound as the epimer of 2a at C-3.
The stereoselective reduction of the 4-hydroxy-3-carbonyl moiety of 1 to produce 2a and 2b can be explained by the transition state structure displayed in Figure 2 . Gatling and Jackson [12] demonstrated that the borohydride reduction of cyclic hydroxyketones is stereo-controlled via OH----BH 4 hydrogen bonding, and yields the trans-diol as the major product (compound 2b). It is interesting that the microbial reduction occurs from the opposite face of the carbonyl group at C-3 of 1 yielding exclusively the cis-diol 2a (Figure 2 ). It is noteworthy that similar stereoselectivity was reported for chemical and microbial reduction of the 3-oxo group in diterpenes displaying methyl groups at C-4 [13, 14] . More importantly, the epimer at C-3 [trans-diol (2b)] occurs in nature [10, 11] , but, thus far, analogs with a 3-hydroxy substituent, as in 2a (cis-diol), have not been encountered as natural products. The absolute stereochemistry of an analogue of 2b, namely chiromodine, has been reported previously [15] . Comparison of data for the latter compound and 2b revealed that these compounds displayed the same relative stereochemistry. Thus, the comparison of optical rotations of 2b and chiromodine suggested that these are quasienantiomers. Based on this comparison, the absolute configuration of 1 and 2a can be predicted as shown in Figure 1 , and revealed that these diterpenes belong to ent-neo trans-clerodane (Type TC) classes [16] .
The biotransformation of 1 was also investigated by the use of growing cells of C. echinulata var. elegans in a semi-solid medium, and by its resting cells as enzyme systems. In both experiments compound 2a was produced as the only product, but in lower yields (85 % and 62 %, respectively) compared with that obtained with the growing cells of C. echinulata in a liquid medium (96 % yield).
Because the biotransformation of 1 by R. stolonifer produced 2a in lower yield (62 %) and over a longer period when compared with C. echinulata var. elegans, we decided to follow the formation of this product as a function of the reaction time. In this case, the experiment was performed using resting cells of R. stolonifer (BRF-130) as the enzyme system, and the product formation was analyzed after 2, 4, 6, 8, 10, 12 and 14 days of reaction. The respective yields were determined by HPLC analyses, and suggested a steady increase of the concentration of 2a with time of the biotransformation reaction. Although only 27 % conversion was observed after 2 days, the yield of 2a continued to increase until day 14 (90 % yield). The yields observed on days 6 and 8 (59 and 65 %, respectively) are in agreement with that obtained (7 days, 62 % yield) when the experiment was performed with growing cells of R. stolonifer (ATCC 6227B).
All compounds (1, 2a and 2b at 5 M concentration) were bioassayed against the human non-small-cell lung cancer (NCI-H460), CNS glioma (SF-268), breast cancer (MCF-7), metastatic prostate adenocarcinoma (PC-3M), and human metastatic breast adenocarcinoma (MDA-MB-231) following the literature procedure [17] . None of them were active, although the moderate cytotoxic activity of compound 2b against the tumor cells lines HeLa (human cervical carcinoma) and L1210 (mouse leukemia) has been reported [11] .
In summary, the clerodane diterpene 3,12-dioxo-15,16-epoxy-4hydroxy-cleroda-13(16),14-diene (1) was stereo and regioselectively bioreduced by whole-cells of C. echinulata var. elegans and R. stolonifer, to yield exclusively the previously unknown cis-1,2-diol analogue (2a). This result suggests the potential application of C. echinulata and R. stolonifer for the bioreduction of clerodane diterpenes.
Experimental
General: Melting points were determined on Electrothermal equipment and are uncorrected. IR spectra were recorded on a Shimadzu FTIR-8300 spectrometer using KBr disks. Optical rotations were acquired in CHCl 3 with a JASCO Dip-370 digital polarimeter. 1 H and 13 C NMR spectra (1D and 2D) were recorded on a Bruker Avance III 400 spectrometer (400 MHz for 1 H NMR and 100 MHz for 13 C NMR) using residual CHCl 3 as internal reference. High-resolution MS were obtained on a Shimadzu TOF spectrometer equipped with an ESI source in positive and negative modes. Analytical thin-layer chromatography (TLC) was performed on pre-coated 0.25 mm thick plates of silica gel 60 F 254 , and the compounds were visualized under a UV lamp (254 nm,) and by spraying with a solution of anisaldehyde in EtOH, followed by heating. Column chromatography was performed using silica gel flash chromatography from J. T. Baker. HPLC analyses were made on a Shimadzu instrument equipped with a LC-20AT high pressure pump and a SPD-M20A photodiode array detector. All solvents, reagents and culture media were purchased from Fisher Chemicals and Sigma-Aldrich.
Isolation of 1:
Dried roots of Croton micans var. argyroglossum (2.9 Kg) were exhaustively extracted with hexanes at room temperature. Evaporation of the solvent under reduced pressure yielded the hexanes extract (95.6 g). A portion of this (35.0 g) was chromatographed over silica gel (75.0 g) by elution with hexanes, CH 2 Cl 2 , EtOAc and MeOH with increasing polarity, to afford 6 fractions (250 mL each). Fraction 2 (12.1 g) obtained with hexanes/CH 2 Cl 2 (1:1), was subjected to successive flash chromatography by elution with hexanes/CH 2 Cl 2 mixtures of increasing polarity to yield 17 sub-fractions (F-1 to F-17). 
Experiments with growing cells of the microorganism:
Spore solutions (OD 600 = 0.6) were prepared from the previously grown fungus in potato dextrose agar (PDA), and transferred (1.0 mL) to 250 mL Erlenmeyer flasks containing 50 mL of the culture medium. The flasks were shaken for 24 h at 28 o C and 160 rpm. After this period, compound 1 (5 mg in 0.5 mL of DMF) was transferred to flasks containing the growing cells of the microorganism. The experiment was performed in duplicate and 2 flasks were used as controls (with no added substrate). After 48 h in a shaker (160 rpm and 28 o C), 10 mL of the culture broth was removed from each flask. The material was extracted with EtOAc (3 x 10 mL). After 7 days of fermentation, flasks containing the remaining 40 mL of medium and the duplicate flasks were used for analysis. For processing of all samples, mycelium was separated from the liquid medium by filtration. The liquid was extracted with EtOAc (3 x 40 mL), and the organic layer was dried with anhydrous Na 2 SO 4 , filtered and concentrated. The mycelium was lyophilized for 24 h, extracted with CHCl 3 /MeOH (1:1), and concentrated. The extracts from liquid medium and mycelium were combined. Experiments performed under semi-solid conditions were also extracted with EtOAc (3 x 40 mL). The product 2a was isolated by preparative TLC (silica gel CHCl 3 /EtOAc 9:1).
Experiments with resting cells of C. echinulata:
A spore solution (1.0 mL; OD 600 = 0.6) of the microorganism was transferred to 4 250 mL Erlenmeyer flasks, each containing 50 mL of the culture medium. After shaking for 24 h (28 o C and 160 rpm), the mycelium in each flask was separated from the liquid medium by filtration, washed twice with 10 mL portions of phosphate buffer solution (pH 7), and each was transferred to a 250 mL Erlenmeyer flask containing 50 mL of phosphate buffer solution (pH 7) and compound 1 (5 mg in 0.5 mL of DMF). Two of these flasks were used as control (no substrate added). After 48 h in a shaker (160 rpm and 28 o C), the mycelium was separated by filtration. The filtrate was extracted with EtOAc (3 x 40 mL), and the organic layer was dried with anhydrous Na 2 SO 4 , filtered and concentrated. The mycelium from each flask was lyophilized for 24 h and extracted with CHCl 3 /MeOH (1:1). The extracts of mycelium and culture media from each experiment were combined and purified by preparative TLC (silica gel; CHCl 3 /EtOAc 9:1) to afford 2a (6.2 mg, 62 %).
Kinetic study on the production of 2a by resting cells of R. stolonifer (BRF-130):
A 7 day old culture of R. stolonifer in potato dextrose agar (PDA) was used to inoculate under aseptic conditions in 250 mL Erlenmeyer flasks containing 100 mL of potato dextrose broth (PDB), previously autoclaved (121 • C for 15 min). After 10 days under static conditions, the mycelium was separated from the liquid medium by filtration under aseptic conditions and washed with distilled water. Each culture flask yielded ca. 30 g of mycelium (wet weight), which was suspended in 100 mL of a phosphate buffer solution (pH 7) containing 9.5 mg of 1. An Erlenmeyer flask with no substrate and another with only the substrate (under similar conditions) were used as controls. The experiments were performed in triplicate. All flasks were shaken at 170 rpm at 23 • C. After 2 days (until day 14) each of the 3 biotransformation flasks was taken for analysis. In the case of the control experiments, 1 mL aliquots were removed from each flask for analysis. The liquid medium was saturated with solid NaCl and extracted with EtOAc (3 x 50 mL), followed by drying with anhydrous Na 2 SO 4 and filtration. The solvent was removed under reduced pressure and the residual material was reconstituted in MeOH (1.0 mg/mL) for HPLC analysis.
Quantitative analysis by HPLC:
For quantitative analysis, standard solutions of compound 2a (40, 80, 100, 200, 300, 400 and 500 ppm) were prepared in MeOH. Each solution was analyzed by HPLC in triplicate as follows: 20 µL as injection volume, Phenomenex™ ODS analytical column (250 mm x 4.6 mm, 5 µm), eluent CH 3 CN/H 2 O (67:33) and flow rate 1.0 mL/min. The response of the obtained standard curve was linear (r 2 = 0.99267) and yielded the following equation: C = -95153.14323 + 22919.41629.A, where C is the concentration (ppm) of compound 2a associated with the peak area (A). After this procedure, the solutions (1.0 mg/mL) of the material obtained in the kinetic experiment above were analyzed under the same conditions. Chemical reduction of 1: Compound 1 (22.5 mg in 1.0 mL of MeOH) was reduced with equimolar amount of NaBH 4 following the literature procedure [2] . Compound 2b (14.8 mg, 65%) was isolated by preparative TLC (silica gel, CH 2 Cl 2 /MeOH 5%). 3R,4S,5S,8S,9R,10S)-3,4-Dihydroxy-15,16-epoxy-12 13 
